Epidemiology of breast cancer in Podkapackie voivodship

Authors

  • Joanna Gustalik Clinical Department of Pathomorphology, Clinical Hospital No. 1, Rzeszów, Poland; Department of Pathomorphology, Faculty of Medicine, University of Rzeszów, Rzeszów, Poland https://orcid.org/0000-0003-0802-9580
  • Dorota Bartusik-Aebisher Department of Biochemistry and General Chemistry, Faculty of Medicine, University of Rzeszów, Rzeszów, Poland https://orcid.org/0000-0002-5557-5464
  • Elżbieta Ostańska Clinical Department of Pathomorphology, Clinical Hospital No. 1, Rzeszów, Poland https://orcid.org/0000-0003-0798-5466
  • Piotr Przyczyna Clinical Department of Pathomorphology, Clinical Hospital No. 1, Rzeszów, Poland; Department of Pathomorphology, Faculty of Medicine, University of Rzeszów, Rzeszów, Poland https://orcid.org/0000-0002-3142-6851
  • Michał Osuchowski Clinical Department of Pathomorphology, Clinical Hospital No. 1, Rzeszów, Poland; Department of Pathomorphology, Faculty of Medicine, University of Rzeszów, Rzeszów, Poland https://orcid.org/0000-0001-6207-7474
  • David Aebisher Department of Photomedicine and Physical Chemistry, Faculty of Medicine, University of Rzeszów, Rzeszów, Poland https://orcid.org/0000-0002-2661-6570
  • Sabina Galiniak Department of Biochemistry and General Chemistry, Faculty of Medicine, University of Rzeszów, Rzeszów, Poland https://orcid.org/0000-0002-1129-3553
  • Ewa Kaznowska Clinical Department of Pathomorphology, Clinical Hospital No. 1, Rzeszów, Poland; Department of Pathomorphology, Faculty of Medicine, University of Rzeszów, Rzeszów, Poland https://orcid.org/0000-0002-4135-0678

DOI:

https://doi.org/10.15584/ejcem.2019.3.7

Keywords:

breast cancer, statistics, epidemiology, Podkarpackie voivodship

Abstract

Introduction. Breast cancer is the second most prevalent reason for cancer deaths after lung cancer. Incidence rates have increased worldwide.

Aim. To present epidemiology of breast cancer in Podkapackie voivodship.

Material and methods. This analysis was performed using a systematic literature search.

Results. In the Podkarpackie voivodship up until 2014, the incidence rate of female breast cancer was rising and in 2015 it dropped by 68 cases. Even though the survival rate is increasing, it is still one of the leading causes of cancer deaths placing second after lung cancer.  

Conclusion. Mortality rate, unfortunately, rose gradually. This shows that even though there is a National Health Program aiming at breast cancer awareness and prevention, it is still not enough to reduce the number of breast cancer deaths. 

Downloads

Download data is not yet available.

References

Winters S, Martin C, Murphy D, Shokar NK. Breast Cancer Epidemiology, Prevention, and Screening. Prog Mol Biol Transl Sci. 2017;151:1-32.

Surdyka JA, Surdyka D, Stanisławek A, Starosławska E, Patyra KI. Selected breast cancer risk factors and early detection of the neoplasm in women from Lublin region attending screening program in St. John's Cancer Center, years 2005-2006. Ann Agric Environ Med. 2014;21(4):792-798.

DeSantis C, Ma J, Bryan L, Jemal A. Breast cancer statistics, 2013. CA Cancer J Clin. 2014 ;64(1):52-62.

DeSantis CE, Lin CC, Mariotto AB, et al. Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin. 2014;64(4):252-271.

Ward EM, DeSantis CE, Lin CC, et al. Cancer statistics: Breast cancer in situ. CA Cancer J Clin. 2015;65(6):481-495.

DeSantis CE, Fedewa SA, Goding Sauer A, Kramer JL, Smith RA, Jemal A. Breast cancer statistics, 2015: Convergence of incidence rates between black and white women. CA Cancer J Clin. 2016;66(1):31-42.

DeSantis CE, Ma J, Goding Sauer A, Newman LA, Jemal A. Breast cancer statistics, 2017, racial disparity in mortality by state. CA Cancer J Clin. 2017;67(6):439-448.

Byrne EM, Ferreira MAR, Xue A, et al. Is Schizophrenia a Risk Factor for Breast Cancer?-Evidence From Genetic Data. Schizophr Bull. 2018;19.

Karadag Arli S, Bakan AB, Aslan G. Distribution of cervical and breast cancer risk factors in women and their screening behaviours. Eur J Cancer Care (Engl). 2018;12:e12960.

Ettinger B, Quesenberry C, Schroeder DA, Friedman G. Long-term postmenopausal estrogen therapy may be associated with increased risk of breast cancer: a cohort study. Menopause. 2018;25(11):1191-1194.

Andersen ZJ, Jørgensen JT, Elsborg L, et al. Long-term exposure to road traffic noise and incidence of breast cancer: a cohort study. Breast Cancer Res. 2018;20(1):119.

Malik SS, Mubarik S, Masood N, Khadim MT. An insight into clinical outcome of XPG polymorphisms in breast cancer. Mol Biol Rep. 2018.

Guinter MA, Sandler DP, McLain AC, Merchant AT, Steck SE. An Estrogen-Related Dietary Pattern and Postmenopausal Breast Cancer Risk in a Cohort of Women with a Family History of Breast Cancer. Cancer Epidemiol Biomarkers Prev. 2018;27(10):1223-1226.

Abubakar M, Sung H, Bcr D, et al. Breast cancer risk factors, survival and recurrence, and tumor molecular subtype: analysis of 3012 women from an indigenous Asian population. Breast Cancer Res. 2018;20(1):114.

Cohn BA, Cirillo PM, La Merrill MA. Correlation of body mass index with serum DDTs predicts lower risk of breast cancer before the age of 50: prospective evidence in the Child Health and Development Studies. J Expo Sci Environ Epidemiol. 2018;17.

Badr LK, Bourdeanu L, Alatrash M, Bekarian G. Breast Cancer Risk Factors: a Cross- Cultural Comparison between the West and the East. Asian Pac J Cancer Prev. 2018;19(8):2109-2116.

Yaghjyan L, Rich S, Mao L, Mai V, Egan KM. Interactions of coffee consumption and postmenopausal hormone use in relation to breast cancer risk in UK Biobank. Cancer Causes Control. 2018;29(6):519-525.

Park JH, Lee SK, Lee JE, et al. Breast Cancer Epidemiology of the Working-Age Female Population Reveals Significant Implications for the South Korean Economy. J Breast Cancer. 2018;21(1):91-95.

Albeshan SM, Mackey MG, Hossain SZ, Alfuraih AA, Brennan PC. Breast Cancer Epidemiology in Gulf Cooperation Council Countries: A Regional and International Comparison.

Williams LA, Olshan AF, Hong CC, et al. Alcohol Intake and Breast Cancer Risk in African American Women from the AMBER Consortium. Cancer Epidemiol Biomarkers Prev. 2017;26(5):787-794.

Rojas K, Stuckey A. Breast Cancer Epidemiology and Risk Factors. Clin Obstet Gynecol. 2016 ;59(4):651-672.

Dubey AK, Gupta U, Jain S. Breast cancer statistics and prediction methodology: a systematic review and analysis. Asian Pac J Cancer Prev. 2015;16(10):4237-45.

Zeng H, Zheng R, Zhang S, Zou X, Chen W. Female breast cancer statistics of 2010 in China: estimates based on data from 145 population-based cancer registries. J Thorac Dis. 2014;6(5):466-470.

Donepudi MS, Kondapalli K, Amos SJ, Venkanteshan P. Breast cancer statistics and markers.

Ghoncheh M, Pournamdar Z, Salehiniya H. Incidence and Mortality and Epidemiology of Breast Cancer in the World. Asian Pac J Cancer Prev. 2016;17(S3):43-46.

Ghoncheh M, Momenimovahed Z, Salehiniya H. Epidemiology, Incidence and Mortality of Breast Cancer in Asia. Asian Pac J Cancer Prev. 2016;17(S3):47-52.

Chang S, El-Zaemey S, Heyworth J, Tang MC. DDT exposure in early childhood and female breast cancer: Evidence from an ecological study in Taiwan. Environ Int. 2018. pii: S0160-4120(18)31599-X.

Hodis HN, Sarrel PM. Menopausal hormone therapy and breast cancer: what is the evidence from randomized trials? Climacteric. 2018;9:1-8.

Chien LH, Tseng TJ, Chen CH, et al. Comparison of annual percentage change in breast cancer incidence rate between Taiwan and the United States-A smoothed Lexis diagram approach. Cancer Med. 2017;6(7):1762-1775.

Carioli G, Malvezzi M, Rodriguez T, Bertuccio P, Negri E, La Vecchia C. Trends and predictions to 2020 in breast cancer mortality: Americas and Australasia. Breast. 2018;37:163-169.

Carioli G, Malvezzi M, Rodriguez T, Bertuccio P, Negri E, La Vecchia C. Trends and predictions to 2020 in breast cancer mortality in Europe. Breast. 2017;36:89-95.

Diniz CSG, Pellini ACG, Ribeiro AG, et al. Breast cancer mortality and associated factors in São Paulo State, Brazil: an ecological analysis. BMJ Open. 2017;7(8):e016395.

Diniz RW, Guerra MR, Cintra JR, Fayer VA, Teixeira MT. Disease-free survival in patients with non-metastatic breast cancer. Rev Assoc Med Bras (1992). 2016;62(5):407-413.

Njor SH, Schwartz W, Blichert-Toft M, Lynge E. Decline in breast cancer mortality: how much is attributable to screening? J Med Screen. 2015;22(1):20-27.

Njor S, Nyström L, Moss S, Paci E, Broeders M, Segnan N, Lynge E; Euroscreen Working Group. Breast cancer mortality in mammographic screening in Europe: a review of incidence-based mortality studies. J Med Screen. 2012;19(1):33-41.

Moss SM, Nyström L, Jonsson H, et al. The impact of mammographic screening on breast cancer mortality in Europe: a review of trend studies. J Med Screen. 2012;19(1):26-32.

Ogunkorode A, Holtslander L, Anonson J, Maree J. Promoting Early Detection of Breast Cancer and Care Strategies for Nigeria. Afr J Reprod Health. 2017;21(2):18-25.

Mora P, Faulkner K, Mahmoud AM, et al. Improvement of early detection of breast cancer through collaborative multi-country efforts: Medical physics component. Phys Med. 2018;48:127-134.

Jiang L, Gilbert J, Langley H, Moineddin R, Groome PA. Breast cancer detection method, diagnostic interval and use of specialized diagnostic assessment units across Ontario, Canada.

Harding C, Pompei F, Burmistrov D, Welch HG, Abebe R, Wilson R. Breast Cancer Screening, Incidence, and Mortality Across US Counties. JAMA Intern Med. 2015;175(9):1483-1489.

Welch HG, Prorok PC, O'Malley AJ, Kramer BS. Breast-Cancer Tumor Size, Overdiagnosis, and Mammography Screening Effectiveness. N Engl J Med. 2016;375(15):1438-1447.

Alba S, Horrillo S, Delemarle V, Pasti Yung V, Thiel C. Raising awareness of organised breast cancer screening. Rev Infirm. 2018;67(244):42-43

DeSantis CE, Fedewa SA, Goding Sauer A, et al. Breast cancer statistics, 2015: Convergence of incidence rates between black and white women. CA Cancer J Clin. 2016;66(1):31-42.

Baquet CR, Mishra SI, Commiskey P, Ellison GL, DeShields M. Breast cancer epidemiology in blacks and whites: disparities in incidence, mortality, survival rates and histology. J Natl Med Assoc. 2008;100(5):480-488.

Downloads

Published

2019-09-30

How to Cite

Gustalik, J., Bartusik-Aebisher, D., Ostańska, E., Przyczyna, P., Osuchowski, M., Aebisher, D., Galiniak, S., & Kaznowska, E. (2019). Epidemiology of breast cancer in Podkapackie voivodship. European Journal of Clinical and Experimental Medicine, 17(3), 242–245. https://doi.org/10.15584/ejcem.2019.3.7

Issue

Vol. 17 No. 3 (2019)

Section

REVIEW PAPERS

License

Copyright (c) 2019 European Journal of Clinical and Experimental Medicine

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Our open access policy is in accordance with the Budapest Open Access Initiative (BOAI) definition: this means that articles have free availability on the public Internet, permitting any users to read, download, copy, distribute, print, search, or link to the full texts of these articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose, without financial, legal, or technical barriers other than those inseparable from having access to the Internet itself.

All articles are published with free open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0). If you submit your paper for publication by the Eur J Clin Exp Med, you agree to have the CC-BY license applied to your work. Under this Open Access license, you, as the author, agree that anyone may download and read the paper for free. In addition, the article may be reused and quoted provided that the original published version is cited. This facilitates freedom in re-use and also ensures that Eur J Clin Exp Med content can be mined without barriers for the research needs.

Most read articles by the same author(s)

1 2 3 4 5 6 > >>